INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106 | -50.0% | 129,289 | -4.7% | 0.01% | -55.6% |
| Q4 2022 | $212 | -99.9% | 135,683 | +6.3% | 0.02% | -10.0% |
| Q3 2022 | $220,000 | -24.1% | 127,683 | -23.8% | 0.02% | -23.1% |
| Q2 2022 | $290,000 | -3.0% | 167,474 | +101.0% | 0.03% | +160.0% |
| Q1 2022 | $299,000 | +109.1% | 83,306 | +191.6% | 0.01% | +100.0% |
| Q4 2021 | $143,000 | -7.7% | 28,570 | +31.8% | 0.01% | -16.7% |
| Q3 2021 | $155,000 | +26.0% | 21,682 | +64.2% | 0.01% | -40.0% |
| Q1 2021 | $123,000 | – | 13,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |